CD8A and neoplasm: The suppressive effects of tumor-treated Cd36−/− BMDMs on CD8+ T cells were reduced when compared with WT BMDMs, as demonstrated by increased GzmB and IFNγ expression of CD8+ T cells (Fig. 6h, i).